AI-generated summary
The authors randomized 130 adults with new sputum smear-positive pulmonary tuberculosis to gallium arsenide laser at 890 nm or sham irradiation alongside standard anti-tuberculosis drugs. They report faster clearance of tubercle bacilli from sputum in the laser group at several time points, which they describe as preliminary evidence. The authors state that these findings are preliminary.
- Participants
- 130
- Who or what was studied
- Adults with new sputum smear-positive pulmonary tuberculosis
- Wavelengths
- 890 nm
- Limits stated in the abstract
- The authors describe the findings as preliminary evidence, and the abstract does not report a control for other factors or details on how sham irradiation was blinded.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 890 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Control group, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.